Skip to main content
. 2005 Nov 14;11(42):6716–6721. doi: 10.3748/wjg.v11.i42.6716

Table 2.

Skp2 protein expression in 138 human gastric cancers

Clinicopathological feature Specimens Skp2 labeling frequency (%)
(n) Mean±SE rho P
Patients 138 36.32±1.22
Age (yr) 138 58.50 0.190 0.833
<60 66 34.25±3.58
≥60 72 34.41±2.63
Gender 0.119 0.179
Females 27 24.96±5.21
Males 111 32.90±2.37
Differentiation grade1 0.315 0.000
Well/Moderate 63 22.41±2.59
Poor 75 38.85±3.10
Depth of invasion 0.001 0.986
Serosal 24 25.84±2.45
Outside soft tissue 114 29.25±4.87
Vessel invasion2 0.303 0.000
Absent 120 27.89±2.11
Present 18 54.39±6.84
Lymph node metastasis3 0.254 0.000
Absent 36 27.94±3.38
Present 102 37.14±2.69
Distant metastasis 0.091 0.307
Absent 26 22.77±6.92
Present 12 31.79±2.38
Clinical stage 0.069 0.440
0 0
Ia 0
Ib 3 22.78±6.92
II 36 29.81±3.14
IIIa 12 44.67±6.78
IIIb 66 34.50±3.55
IV 9 53.00±0.57

1, 2, 3Skp2 labeling frequency was positively correlated with differentiated degree (rho = 0.315, P = 0.000), vessel invasion (rho = 0.303, P = 0.000), and lymph node metastasis (rho = 0.254, P = 0.000) in gastric carcinoma, respectively. 4Because clinical staging could not be performed due to the lack of accurate records about lymph node in operation, data of 12 cases were cancelled in statistical analysis.